1
|
Ferrara PJ, Rong X, Maschek JA, Verkerke AR, Siripoksup P, Song H, Green TD, Krishnan KC, Johnson JM, Turk J, Houmard JA, Lusis AJ, Drummond MJ, McClung JM, Cox JE, Shaikh SR, Tontonoz P, Holland WL, Funai K. Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle. J Clin Invest 2021; 131:135963. [PMID: 33591957 DOI: 10.1172/jci135963] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2019] [Accepted: 02/11/2021] [Indexed: 01/09/2023] Open
Abstract
Aberrant lipid metabolism promotes the development of skeletal muscle insulin resistance, but the exact identity of lipid-mediated mechanisms relevant to human obesity remains unclear. A comprehensive lipidomic analysis of primary myocytes from individuals who were insulin-sensitive and lean (LN) or insulin-resistant with obesity (OB) revealed several species of lysophospholipids (lyso-PLs) that were differentially abundant. These changes coincided with greater expression of lysophosphatidylcholine acyltransferase 3 (LPCAT3), an enzyme involved in phospholipid transacylation (Lands cycle). Strikingly, mice with skeletal muscle-specific knockout of LPCAT3 (LPCAT3-MKO) exhibited greater muscle lysophosphatidylcholine/phosphatidylcholine, concomitant with improved skeletal muscle insulin sensitivity. Conversely, skeletal muscle-specific overexpression of LPCAT3 (LPCAT3-MKI) promoted glucose intolerance. The absence of LPCAT3 reduced phospholipid packing of cellular membranes and increased plasma membrane lipid clustering, suggesting that LPCAT3 affects insulin receptor phosphorylation by modulating plasma membrane lipid organization. In conclusion, obesity accelerates the skeletal muscle Lands cycle, whose consequence might induce the disruption of plasma membrane organization that suppresses muscle insulin action.
Collapse
Affiliation(s)
- Patrick J Ferrara
- Diabetes and Metabolism Research Center and.,Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.,East Carolina Diabetes and Obesity Institute and.,Human Performance Laboratory, East Carolina University, Greenville, North Carolina, USA.,Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA
| | - Xin Rong
- Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, USA
| | - J Alan Maschek
- Diabetes and Metabolism Research Center and.,Metabolomics, Mass Spectrometry, and Proteomics Core and
| | - Anthony Rp Verkerke
- Diabetes and Metabolism Research Center and.,Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.,East Carolina Diabetes and Obesity Institute and.,Human Performance Laboratory, East Carolina University, Greenville, North Carolina, USA
| | - Piyarat Siripoksup
- Diabetes and Metabolism Research Center and.,Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA
| | - Haowei Song
- Division of Endocrinology Metabolism and Lipid Research, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA
| | | | | | - Jordan M Johnson
- Diabetes and Metabolism Research Center and.,Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.,East Carolina Diabetes and Obesity Institute and.,Human Performance Laboratory, East Carolina University, Greenville, North Carolina, USA
| | - John Turk
- Division of Endocrinology Metabolism and Lipid Research, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA
| | - Joseph A Houmard
- East Carolina Diabetes and Obesity Institute and.,Human Performance Laboratory, East Carolina University, Greenville, North Carolina, USA
| | - Aldons J Lusis
- Cardiology Division, Department of Medicine, UCLA, Los Angeles, California, USA
| | - Micah J Drummond
- Diabetes and Metabolism Research Center and.,Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.,Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA
| | | | - James E Cox
- Diabetes and Metabolism Research Center and.,Metabolomics, Mass Spectrometry, and Proteomics Core and.,Department of Biochemistry, University of Utah, Salt Lake City, Utah, USA
| | - Saame Raza Shaikh
- East Carolina Diabetes and Obesity Institute and.,Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Peter Tontonoz
- Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, USA
| | - William L Holland
- Diabetes and Metabolism Research Center and.,Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.,Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA
| | - Katsuhiko Funai
- Diabetes and Metabolism Research Center and.,Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.,East Carolina Diabetes and Obesity Institute and.,Human Performance Laboratory, East Carolina University, Greenville, North Carolina, USA.,Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.,Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA
| |
Collapse
|